Skip to main content

Advertisement

Log in

Polymorphisms in genes HSD17B1 and HSD17B2 and uterine leiomyoma risk in Chinese women

  • Gynecologic Oncology
  • Published:
Archives of Gynecology and Obstetrics Aims and scope Submit manuscript

Abstract

Purpose

To evaluate the association of HSD17B1 and HSD17B2 gene polymorphisms with uterine leiomyoma in Chinese women.

Methods

121 Chinese women with clinically diagnosed uterine leiomyoma and 217 healthy normal Chinese women were investigated to compare three single nucleotide polymorphisms (SNPs) (rs605059 and rs676387 of HSD17B1 gene and rs8191246 of HSD17B2 gene) by polymerase chain reaction–restriction fragment length polymorphism and DNA sequencing method.

Results

All the SNPs were polymorphisms in Chinese women. Frequencies of rs605059 AA genotype and A allele were significantly increased in patients with uterine leiomyoma compared to healthy controls (GG vs. AA, OR 0.40, 95 % CI 0.20–0.82; G vs. A, OR 0.68, 95 % CI 0.50–0.94).

Conclusion

The results suggest that the genotype of HSD17B1 rs605059 may play a role in the tumourgenesis of uterine leiomyoma.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Haney AF (2000) Clinical decision making regarding leiomyomata: what we need in the next millenium. Environ Health Perspect 108(Suppl 5):835–839

    PubMed  Google Scholar 

  2. Lethaby A, Vollenhoven B (2005) Fibroids (uterine myomatosis, leiomyomas). Clin Evid (14):2264–2282

  3. Maruo T, Ohara N, Wang J, Matsuo H (2004) Sex steroidal regulation of uterine leiomyoma growth and apoptosis. Hum Reprod Update 10:207–220

    Article  PubMed  CAS  Google Scholar 

  4. Walker CL, Stewart EA (2005) Uterine fibroids: the elephant in the room. Science 308:1589–1592

    Article  PubMed  CAS  Google Scholar 

  5. Miettinen M, Mustonen M, Poutanen M, Isomaa V, Wickman M, Soderqvist G et al (1999) 17Beta-hydroxysteroid dehydrogenases in normal human mammary epithelial cells and breast tissue. Breast Cancer Res Treat 57:175–182

    Article  PubMed  CAS  Google Scholar 

  6. Vihko P, Harkonen P, Soronen P, Torn S, Herrala A, Kurkela R et al (2004) 17Beta-hydroxysteroid dehydrogenases—their role in pathophysiology. Mol Cell Endocrinol 215:83–88

    Article  PubMed  CAS  Google Scholar 

  7. Jansson A, Gunnarsson C, Stal O (2006) Proliferative responses to altered 17beta-hydroxysteroid dehydrogenase (17HSD) type 2 expression in human breast cancer cells are dependent on endogenous expression of 17HSD type 1 and the oestradiol receptors. Endocr Relat Cancer 13:875–884

    Article  PubMed  CAS  Google Scholar 

  8. Hsieh YY, Chang CC, Tsai FJ, Lin CC, Tsai CH (2008) T allele for VEGF-460 gene polymorphism at 5′-untranslated region is associated with higher susceptibility of leiomyoma. Biochem Genet 46:356–361

    Article  PubMed  CAS  Google Scholar 

  9. Morikawa J, Yoshida S, Kennedy S, Takemura N, Sugimoto M, Kitao K et al (2008) Association study between catechol-O-methyltransferase polymorphisms and uterine leiomyomas in a Japanese population. Clin Exp Obstet Gynecol 35:35–40

    PubMed  CAS  Google Scholar 

  10. Villanova FE, Andrade PM, Otsuka AY, Gomes MT, Leal ES, Castro RA et al (2006) Estrogen receptor alpha polymorphism and susceptibility to uterine leiomyoma. Steroids 71:960–965

    Article  PubMed  CAS  Google Scholar 

  11. Ye Y, Cheng X, Luo HB, Liu L, Li YB, Hou YP (2008) CYP1A1 and CYP1B1 genetic polymorphisms and uterine leiomyoma risk in Chinese women. J Assist Reprod Gen 25:389–394

    Article  Google Scholar 

  12. Hsieh YY, Chang CC, Tsai FJ, Lin CC, Yeh LS, Peng CT (2004) Androgen receptor trinucleotide polymorphism in leiomyoma. J Assist Reprod Genet 21:453–457

    Article  PubMed  Google Scholar 

  13. Peltoketo H, Luu-The V, Simard J, Adamski J (1999) 17Beta-hydroxysteroid dehydrogenase (HSD)/17-ketosteroid reductase (KSR) family; nomenclature and main characteristics of the 17HSD/KSR enzymes. J Mol Endocrinol 23:1–11

    Article  PubMed  CAS  Google Scholar 

  14. Mannermaa A, Peltoketo H, Winqvist R, Ponder BA, Kiviniemi H, Easton DF et al (1994) Human familial and sporadic breast cancer: analysis of the coding regions of the 17 beta-hydroxysteroid dehydrogenase 2 gene (EDH17B2) using a single-strand conformation polymorphism assay. Hum Genet 93:319–324

    Article  PubMed  CAS  Google Scholar 

  15. Normand T, Narod S, Labrie F, Simard J (1993) Detection of polymorphisms in the estradiol 17 beta-hydroxysteroid dehydrogenase II gene at the EDH17B2 locus on 17q11-q21. Hum Mol Genet 2:479–483

    Article  PubMed  CAS  Google Scholar 

  16. Lamp M, Peters M, Reinmaa E, Haller-Kikkatalo K, Kaart T, Kadastik U et al (2011) Polymorphisms in ESR1, ESR2 and HSD17B1 genes are associated with fertility status in endometriosis. Gynecol Endocrinol 27:425–433

    Article  PubMed  CAS  Google Scholar 

  17. Katoh T, Tsuchiya M, Nakao H, Sasaki H, Hiroshima M, Tanaka T et al (2005) Association between endometriosis and genetic polymorphisms of the estradiol-synthesizing enzyme genes HSD17B1 and CYP19. Hum Reprod 20:974–978

    PubMed  Google Scholar 

  18. Lee IW, Kuo PH, Su MT, Kuan LC, Hsu CC, Kuo PL (2011) Quantitative trait analysis suggests polymorphisms of estrogen-related genes regulate human sperm concentrations and motility. Hum Reprod 26:1585–1596

    Article  PubMed  CAS  Google Scholar 

  19. Sainz J, Rudolph A, Hein R, Hoffmeister M, Buch S, von Schonfels W et al (2011) Association of genetic polymorphisms in ESR2, HSD17B1, ABCB1, and SHBG genes with colorectal cancer risk. Endocr Relat Cancer 18:265–276

    Article  PubMed  CAS  Google Scholar 

  20. Feigelson HS, Cox DG, Cann HM, Wacholder S, Kaaks R, Henderson BE et al (2006) Haplotype analysis of the HSD17B1 gene and risk of breast cancer: a comprehensive approach to multicenter analyses of prospective cohort studies. Cancer Res 66:2468–2475

    Article  PubMed  CAS  Google Scholar 

  21. Kraft P, Pharoah P, Chanock SJ, Albanes D, Kolonel LN, Hayes RB et al (2005) Genetic variation in the HSD17B1 gene and risk of prostate cancer. PLoS Genet 1:e68

    Article  PubMed  Google Scholar 

  22. Husen B, Psonka N, Jacob-Meisel M, Keil C, Rune GM (2000) Differential expression of 17 beta-hydroxysteroid dehydrogenases types 2 and 4 in human endometrial epithelial cell lines. J Mol Endocrinol 24:135–144

    Article  PubMed  CAS  Google Scholar 

  23. Yang SJ, Fang ZJ, Gurates B, Tamura M, Miller J, Ferrer K et al (2001) Stromal PRs mediate induction of 17 beta-hydroxysteroid dehydrogenase type 2 expression in human endometrial epithelium: a paracrine mechanism for inactivation of E2. Mol Endocrinol 15:2093–2105

    Article  PubMed  CAS  Google Scholar 

  24. Andersson S, Moghrabi N (1997) Physiology and molecular genetics of 17 beta-hydroxysteroid dehydrogenases. Steroids 62:143–147

    Article  PubMed  CAS  Google Scholar 

  25. Moghrabi N, Head JR, Andersson S (1997) Cell type-specific expression of 17 beta-hydroxysteroid dehydrogenase type 2 in human placenta and fetal liver. J Clin Endocr Metab 82:3872–3878

    Article  PubMed  CAS  Google Scholar 

  26. Elo JP, Harkonen P, Kyllonen AP, Lukkarinen O, Poutanen M, Vihko R et al (1997) Loss of heterozygosity at 16q24.1-q24.2 is significantly associated with metastatic and aggressive behavior of prostate cancer. Cancer Res 57:3356–3359

    PubMed  CAS  Google Scholar 

  27. Kuo PL, Su MT, Chen CH, Kuo PH, Hsu CC, Lee IW et al (2010) Polymorphisms of estrogen-related genes jointly confer susceptibility to human spermatogenic defect. Fertil Steril 93:141–149

    Article  PubMed  Google Scholar 

  28. Warren R, Skinner J, Sala E, Denton E, Dowsett M, Folkerd E et al (2006) Associations among mammographic density, circulating sex hormones, and polymorphisms in sex hormone metabolism genes in postmenopausal women. Cancer Epidemiol Biomarkers 15:1502–1508

    Article  CAS  Google Scholar 

  29. Karageorgi S, McGrath M, Lee IM, Buring J, Kraft P, De Vivo I (2011) Polymorphisms in genes hydroxysteroid-dehydrogenase-17b type 2 and type 4 and endometrial cancer risk. Gynecol Oncol 121:54–58

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

This work was financially supported by Opening Fund of Shanghai Key Laboratory of Forensic Medicine (Grant No. KF1002) and Research Fund for the Doctoral Program of Higher Education of China (Grant No. 200806101086).

Conflict of interest

None.

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Jing Yan or Ying-Bi Li.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Cong, RJ., Huang, ZY., Cong, L. et al. Polymorphisms in genes HSD17B1 and HSD17B2 and uterine leiomyoma risk in Chinese women. Arch Gynecol Obstet 286, 701–705 (2012). https://doi.org/10.1007/s00404-012-2328-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00404-012-2328-0

Keywords

Navigation